Charles Russell Taylor, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultraviolet Therapy | 9 | 2006 | 84 | 1.480 |
Why?
|
| Laser Therapy | 12 | 2004 | 1092 | 1.300 |
Why?
|
| Psoriasis | 12 | 2008 | 944 | 1.190 |
Why?
|
| Scalp Dermatoses | 4 | 2004 | 44 | 0.730 |
Why?
|
| Pityriasis Lichenoides | 1 | 2009 | 6 | 0.350 |
Why?
|
| PUVA Therapy | 3 | 1999 | 101 | 0.330 |
Why?
|
| Skin | 8 | 2009 | 4473 | 0.280 |
Why?
|
| Lichen Planus, Oral | 1 | 2004 | 57 | 0.220 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 2 | 1999 | 46 | 0.210 |
Why?
|
| Photosensitivity Disorders | 2 | 1999 | 80 | 0.200 |
Why?
|
| Vitiligo | 1 | 2003 | 96 | 0.200 |
Why?
|
| Lichen Planus | 1 | 2002 | 70 | 0.190 |
Why?
|
| Foot Dermatoses | 2 | 2006 | 47 | 0.180 |
Why?
|
| Hand Dermatoses | 2 | 2006 | 62 | 0.180 |
Why?
|
| Methoxsalen | 1 | 1999 | 21 | 0.170 |
Why?
|
| Electrosurgery | 1 | 2000 | 51 | 0.170 |
Why?
|
| Erythema | 2 | 1999 | 262 | 0.170 |
Why?
|
| Aminolevulinic Acid | 3 | 2008 | 144 | 0.170 |
Why?
|
| Keloid | 1 | 1999 | 54 | 0.160 |
Why?
|
| Product Labeling | 1 | 1999 | 76 | 0.150 |
Why?
|
| Indicators and Reagents | 1 | 1999 | 460 | 0.150 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1999 | 239 | 0.150 |
Why?
|
| Ultraviolet Rays | 3 | 2005 | 1079 | 0.140 |
Why?
|
| Phototherapy | 1 | 1999 | 368 | 0.130 |
Why?
|
| Nevus of Ota | 1 | 1994 | 3 | 0.120 |
Why?
|
| Medical Audit | 1 | 1995 | 453 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 11069 | 0.120 |
Why?
|
| Skin Pigmentation | 4 | 2003 | 277 | 0.120 |
Why?
|
| Lentigo | 1 | 1993 | 37 | 0.110 |
Why?
|
| Photochemotherapy | 3 | 2008 | 823 | 0.110 |
Why?
|
| Melanosis | 1 | 1994 | 93 | 0.110 |
Why?
|
| Severity of Illness Index | 8 | 2006 | 15828 | 0.110 |
Why?
|
| Alopecia Areata | 1 | 1995 | 128 | 0.110 |
Why?
|
| Hyperpigmentation | 1 | 1994 | 116 | 0.110 |
Why?
|
| Temperature | 1 | 1999 | 2223 | 0.100 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2002 | 880 | 0.100 |
Why?
|
| Pigments, Biological | 1 | 1991 | 52 | 0.100 |
Why?
|
| Nevus, Pigmented | 1 | 1993 | 222 | 0.090 |
Why?
|
| Tattooing | 1 | 1991 | 57 | 0.090 |
Why?
|
| Radiometry | 2 | 2008 | 812 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 1999 | 1661 | 0.090 |
Why?
|
| Photosensitizing Agents | 3 | 2008 | 623 | 0.090 |
Why?
|
| Pilot Projects | 5 | 2008 | 8618 | 0.080 |
Why?
|
| Radiotherapy Dosage | 3 | 2003 | 2897 | 0.080 |
Why?
|
| Curettage | 2 | 2000 | 74 | 0.080 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2009 | 85 | 0.080 |
Why?
|
| Singlet Oxygen | 1 | 2008 | 58 | 0.080 |
Why?
|
| Epidermis | 2 | 2005 | 527 | 0.070 |
Why?
|
| Pharyngitis | 1 | 2009 | 220 | 0.070 |
Why?
|
| Lymphoma | 1 | 1997 | 1899 | 0.070 |
Why?
|
| Adult | 22 | 2008 | 220969 | 0.070 |
Why?
|
| Lasers | 1 | 1991 | 952 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 340 | 0.070 |
Why?
|
| Middle Aged | 19 | 2008 | 220584 | 0.070 |
Why?
|
| Male | 26 | 2009 | 360358 | 0.070 |
Why?
|
| Treatment Outcome | 10 | 2006 | 64568 | 0.070 |
Why?
|
| Follow-Up Studies | 7 | 2004 | 39063 | 0.060 |
Why?
|
| Neck | 1 | 2009 | 734 | 0.060 |
Why?
|
| Exanthema | 1 | 2009 | 503 | 0.060 |
Why?
|
| Female | 25 | 2008 | 392148 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 1994 | 5812 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.060 |
Why?
|
| Humans | 33 | 2009 | 760617 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2009 | 1077 | 0.060 |
Why?
|
| Keratosis | 1 | 2004 | 79 | 0.060 |
Why?
|
| Keratinocytes | 3 | 2005 | 790 | 0.060 |
Why?
|
| Probability | 2 | 2004 | 2475 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2009 | 718 | 0.050 |
Why?
|
| Facial Dermatoses | 1 | 2004 | 86 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2004 | 615 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2849 | 0.050 |
Why?
|
| Fever | 1 | 2009 | 1618 | 0.050 |
Why?
|
| Biopsy | 2 | 2009 | 6762 | 0.050 |
Why?
|
| Melanocytes | 2 | 1994 | 509 | 0.050 |
Why?
|
| Desiccation | 1 | 2000 | 78 | 0.040 |
Why?
|
| Skin Temperature | 1 | 1999 | 96 | 0.040 |
Why?
|
| Ventilation | 1 | 1999 | 128 | 0.040 |
Why?
|
| Treatment Failure | 2 | 1995 | 2635 | 0.040 |
Why?
|
| Skin Diseases | 1 | 2006 | 1094 | 0.040 |
Why?
|
| Aged | 9 | 2006 | 169042 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 14648 | 0.030 |
Why?
|
| Equipment Design | 1 | 2004 | 3501 | 0.030 |
Why?
|
| Acne Vulgaris | 1 | 2000 | 349 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 1994 | 41 | 0.030 |
Why?
|
| Hypopigmentation | 1 | 1994 | 43 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12966 | 0.030 |
Why?
|
| Adolescent | 7 | 2006 | 88234 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2004 | 58894 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 1148 | 0.030 |
Why?
|
| Remission Induction | 1 | 1999 | 2391 | 0.030 |
Why?
|
| Time Factors | 3 | 2003 | 39913 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 1998 | 1624 | 0.030 |
Why?
|
| Sensation | 1 | 1994 | 336 | 0.030 |
Why?
|
| Melanins | 1 | 1994 | 289 | 0.030 |
Why?
|
| Life Tables | 1 | 1991 | 364 | 0.020 |
Why?
|
| Recurrence | 1 | 2003 | 8426 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1997 | 938 | 0.020 |
Why?
|
| Administration, Topical | 2 | 2004 | 703 | 0.020 |
Why?
|
| Cell Division | 1 | 1997 | 4457 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 2561 | 0.020 |
Why?
|
| Scleredema Adultorum | 1 | 2006 | 2 | 0.020 |
Why?
|
| Urticaria Pigmentosa | 1 | 2006 | 16 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1997 | 2689 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 13347 | 0.020 |
Why?
|
| Prognosis | 2 | 1998 | 29600 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 20556 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 1998 | 8516 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2005 | 12116 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 68 | 0.020 |
Why?
|
| Carcinoma | 1 | 1997 | 2327 | 0.020 |
Why?
|
| Child | 4 | 2006 | 80079 | 0.020 |
Why?
|
| Pharmaceutical Solutions | 1 | 2004 | 15 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2006 | 42188 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 59179 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 1991 | 1956 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 23972 | 0.010 |
Why?
|
| Medical Records | 1 | 2006 | 1407 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2697 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1503 | 0.010 |
Why?
|
| Infant | 2 | 1999 | 36152 | 0.010 |
Why?
|
| Dehydrocholesterols | 1 | 1999 | 20 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1575 | 0.010 |
Why?
|
| Protective Clothing | 1 | 1999 | 103 | 0.010 |
Why?
|
| Dermatitis, Atopic | 1 | 2006 | 731 | 0.010 |
Why?
|
| Sunscreening Agents | 1 | 1999 | 139 | 0.010 |
Why?
|
| Psychometrics | 1 | 2008 | 3060 | 0.010 |
Why?
|
| Dermatitis | 1 | 2000 | 202 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2894 | 0.010 |
Why?
|
| Algorithms | 1 | 1997 | 14018 | 0.010 |
Why?
|
| United States | 2 | 2006 | 72272 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 5491 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7798 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 80566 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4845 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 18937 | 0.010 |
Why?
|
| Apoptosis | 1 | 2005 | 9476 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1991 | 41457 | 0.000 |
Why?
|
| Mice | 1 | 2005 | 81368 | 0.000 |
Why?
|
| Animals | 1 | 2005 | 168201 | 0.000 |
Why?
|